Mailchimp plans to expand as a full-service marketing platform
By Nikita Chaurasia  Date: 2019-05-15

Mailchimp plans to expand as a full-service marketing platform

The company has described the move as the biggest shift in its 20-year history.

Marketing automation platform Mailchimp has reportedly announced that it has planned to expand beyond its core business by introducing a completely new product suite and a key pivot in business strategy. The company has described the move as the biggest shift in its 20-year history. Mailchimp is aiming to become an all-in-one marketing platform for small businesses, with integrated CRM at its center.

Reportedly, for the last two years, Mailchimp has moved beyond email by introducing features like Facebook ads, landing pages, social posting, Google remarketing ads, and some marketing CRM tools. The announcement of business expansion has brought all the previously introduced tools together into a single platform with tiered pricing, along with CRM and new website builder product.

 On the CRM side, Mailchimp has earlier presented tagging and more product features. The company will now expand that functionality so that users can gather information, understand audience, and act on insights all from within one platform. The users of Mailchimp will be able to tag customers with integrated CRM for more focused marketing based on interactions, clicks and open rates. The platform will also provide tips to transform audiences into paying customers.

As for websites, among 11 million active users of Mailchimp, roughly 10 percent don’t have their own websites, pushing the launch of its current landing page function. The website builder is available in beta and will create a simple website from templates. General information about a business and engagement opportunities, such as on one or more pages linked together with a navigation, downloads or commerce, will be provided through website.

Additional platform features include the ability to send recurring postcards to audiences to encourage sales; the ability to repurpose current social content to Twitter, Facebook and Instagram; and new ad retargeting capabilities on Instagram and Facebook.

Source credit: https://www.zdnet.com/article/mailchimp-expands-beyond-email-aims-to-be-full-service-marketing-provider-for-smbs/

https://mailchimp.com/announcements/ben/mailchimps-evolution/

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Fragomen acquires SimpleCitizen to reinforce its immigration services
Fragomen acquires SimpleCitizen to reinforce its immigration services
By Nikita Chaurasia

In a recent turn of events, Fragomen, Del Rey, Bernsen & Loewy, LLP, a leading corporate immigration law company has reportedly joined hands with SimpleCitizen Inc. to form Fragomen Technologies Inc., a new subsidiary which will provide a combina...

Nautilus buys 17 MW portfolio from solar energy developer Pine Gate
Nautilus buys 17 MW portfolio from solar energy developer Pine Gate
By Nikita Chaurasia

Solar project development and asset management major, Nautilus Solar Energy LLC, has reportedly announced its acquisition of two solar portfolios in Rhode Island and Oregon amounting to a total of nearly 17 MW from leading solar energy developer, Pin...

Locate Bio obtains multiple late stage orthobiologics assets from RCSI
Locate Bio obtains multiple late stage orthobiologics assets from RCSI
By Nikita Chaurasia

Regenerative medicine major, Locate Bio, has reportedly announced its in-licensing of several late stage orthobiologics assets from the RCSI University of Medicine and Health Sciences. Sources state that the technologies created by the RCSI Tissue E...

Roche acquires Inflazome to gain control over inflammatory treatments
Roche acquires Inflazome to gain control over inflammatory treatments
By Nikita Chaurasia

In a recent turn of events, Swiss healthcare giant, F. Hoffmann-La Roche AG has reportedly acquired an Irish biotech firm Inflazome Ltd. for approximately USD 451 million (€380 million). As per the agreement, Roche will acquire complete rights ...

Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
By Nikita Chaurasia

Innovent Biologics Inc., in collaboration with American pharmaceutical giant Eli Lilly and Company, have reportedly announced that the biomarker results of ORIENT-11 trials which were displayed during a mini verbal presentation at ESMO (European Soci...